Two Humans

Price Rationale

The reconciled value centers near the appraiser average and the cultural-canon mark: Two Humans is a May 2018 SuperRare XCOPY 1/1 with supply 1 and early provenance, which supports a meaningful premium over its stale 0.5 ETH 2019 sale. However, liquidity evidence is weak: no current ask, no current best bid, no OTC history, no grail flag, and no outgoing candidate benchmark count. A 70 ETH fair value balances the stronger early-XCOPY scarcity argument against the liquidity and cycle appraisers' lower executable-sale view, placing the work below more validated early/non-grail anchors around 100+ ETH while above distressed or purely stale-sale marks.

What Caps The Price

A higher valuation is not supported by token-specific evidence. The packet shows only one exact-token sale from 2019 at 0.5 ETH, no live bid or ask, no OTC sale history, no grail designation, and no benchmark candidate set. Comparable sales above 100 ETH exist in the supplied context, but they appear to involve stronger, better-validated, more liquid, or more culturally salient works and should not be transferred directly to this token.

What Supports The Price

A lower valuation would over-penalize the stale 2019 print and ignore the work's early May 2018 SuperRare XCOPY 1/1 status. The supplied appraisals consistently recognize that early XCOPY 1/1s have repriced far above their 2018-2019 sale levels, and even the liquidity-focused marks place meaningful value on age, scarcity, and artist provenance.